ACTRN12615000330549终止未知
Effectiveness of Stereotactic Hypofractionated body radiosurgery for Oligometastatic Renal cell Tumours upfront, with Systemic Targeted agents On Progression
Peter MacCallum Cancer Centre0 个研究点目标入组 30 人开始时间: 2015年4月10日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 终止
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •Aged 18 years or older
- •- Histological or cytologically confirmed renal cell carcinoma
- •- Bone Scan or CT Scan evidence of 1 to 3 extracranial metastases in patients with no prior systemic targeted therapy
- •-Bone Scan or CT Scan evidence of 4 to 6 extracranial metastases in patients currently on systemic targeted therapy AND no more than 1 to 3 progressing metastases
- •- An ECOG performance status score of 2 or less
- •- Life expectancy greater than 9 months
- •- Available for follow up
排除标准
- •- Previous high dose radiotherapy (BED > 20Gy) to the area to be treated
- •- Intracranial metastases not controlled by previous surgery or stereotactic radiotherapy
- •- Chemotherapy within +/- 3 weeks of SABR
- •- Systemic targeted agents within +/- 7 days of SABR
- •- Evidence of Spinal Cord Compression
- •- Spinal Instability Neoplastic Score >= 7 unless case has been reviewed by a neurosurgical service and considered stable
- •- Long bone Mirels score >= 7 unless reviewed by an orthopaedic service and considered stable
研究者
相似试验
招募中
3 期
Efficacy and Safety of Fractionated Stereotactic Radiation Therapy (FSRT) versus Single Fraction Stereotactic Radiosurgery (SRS) for Large Brain Metastases (2 - 4 cm)C79.3Secondary malignant neoplasm of brain and cerebral meningesDRKS00015647niversitätsklinikum Erlangen382
招募中
不适用
Phase II study of hypofractionated stereotactic body radiation therapy for prostate cancerProstate cancerJPRN-UMIN000014671Radiation Oncology, Tokai University Hachioji Hospital20
终止
2 期
Study to assess the neurological and cognitive effects of using Hypofractionated Stereotactic Radiotherapy used to treat multiple (3-10) brain metastases.eurocognitive impairmentNeurocognitive impairmentCancer - Any cancerCancer - BrainACTRN12615001202550Icon Cancer Foundation30
招募中
2 期
A study on the safety and efficacy of hypofractionated radiotherapy in post-operative irradiation for breast cancer patientsBreast cancerJPRN-UMIN000010977ational Institute of Radiological Sciences400
已完成
2 期
Hypofractionated stereotactic radiotherapy for large brain metastasesBrain metastasesJPRN-UMIN000010112Department of Radiology, Nagoya City University Graduate School of Medical Sciences90